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THE ETIOLOGY AND TREATMENT OF PEMPHIGIJS AND
PEMPHIGOID*
WALTER F. LEVER, M.D.t AND KEN HASHIMOTO, M.D.1:
In 1936, when I began my training in der-
matology, pemphigus Vulgaris was the derma-
tosis that impressed me the most. It was a
puzzling and frightening disease with its in-
sidious onset, the gradual worsening until
large areas of the skin were affected, and the
inevitability of death. Nothing was known
about the cause or the reason why the patients
died even though none of the internal organs
were involved. No effective treatment existed.
In order to study this disease, I, after finishing
my residency at the Massachusetts General
Hospital, became a research fellow in Dr. John
H. Talbott's laboratory where, together, we
investigated the electrolyte concentration in
the blood serum and blister fluid of patients
with pemphigus. Since we found a decrease in
the serum concentration of sodium and chloride
and an increase in potassium, as in Addison's
disease, we treated pemphigus with large doses
of adrenal cortex extract and were able to
bring about at least temporary remissions (1).
We also recognized at that time, that two
different diseases were included in pemphigus
vulgaris and referred to them as acute and
chronic pemphigus vulgaris, the latter being
the disease that later on I described as bullous
pemphigold (2).
Great progress has been made in the thirty
years since then in the understanding and in
the treatment of pemphigus and of bullous
pemphigoid and I would like to list the follow-
ing milestones:
First, came the description of the process of
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acantholysis in pemphigus vulgaris by Civatte
(3) in 1943, on the basis of which pemphigus
vulgaris and bullous pemphigoid could be
clearly distinguished on a histologic basis.
Second, in 1959, came the introduction of
the corticosteroids into the treatment of pem-
phigus and bullous pemphigoid, with the
recognition that very large initial doses were
required in pemphigus vulgaris in order to save
the patient's life.
Third, in 1964, Beutner and Jordon (4) de-
scribed the presence of specific autoantibodies
in the serum of patients with pemphigus and
bulluous pemphigoid. That these diseases prob-
ably are manifestations of autoimmunity has
been strongly suggested by experimental studies,
especially by the in vivo production of inter-
cellular antibodies and of acantholysis in rab-
bits by Inderbitzin and Grob (5, 6). Also, the
favorable results obtained with methotrexate
and the treatment of both pemphigus and
bullous pemphigoid favor the concept of an
autoimmune etiology for these diseases.
Fina1ly, the electron microscopic studies by
Hashimoto (7, 8) of the changes iii the inter-
cellular cement substance have contributed
greatly to the understanding of the mechanism
of bulla formation in pemphigus.
I. AIJTOIMMUNE ETIOLOGY
Let us first examine the evidence available
to indicate that pemphigus and bullous pem-
phigoid are autoimmune diseases.
a. Pemphigus
In pemphigus vulgaris as well as in pem-
phigus fo1iaceus the serum contains antibodies
against the intercellular substance of stratified
epithelium, as demonstrated by means of in-
direct immunofluorescent staining (Fig. 1).
The points in favor of an autoimmune etiology
for pemphigus are the following:
1. The intercellular antibodies are autoanti-
bodies since performing indirect immunofluores-
cent staining using a patient's serum on sec-
tions of his own skin biopsy gives a positive
result (9).
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Fm. 1. Pemphigus vulgoris. Indirect immunofiuorescent staining shows binding of anti-
boches in the intercellular spaces of stratified epithelium.
2. The localization of the intercelhilar anti-
hndies of pemphigus corresponds to the site
where aeantholysis takes place.
3. The titer of the intercellular antibodies
in general is proportional to the severity of the
disease. Thus, patients with extensive lesions
usually show a positive reaction at a titer of
1: 120, and occasionally even at 1:640; whereas
patients with moderate involvement, as a rule,
have a titer of 1:20 to 1:80; and the patients
in the early stage of the disease who have only
a few lesions usually show a negative test (10).
4. Both JgG and complement are hound
in vivo to the intercellular areas of the squa-
mous epithelium of a patient's own skin biopsy
suggesting a pathologic effect of the autoanti-
bodies in the intercellular area (11).
Immunization of rabbits with a fraction of
stratified squamous epithelium from rabbit
esophagus produces antibodies in their serum
which, on indirect immunofiuorescent testing,
are indistinguishable from pemphigus anti-
bodies (5). In such immunized rabbits with
high titers of intercellular antibodies, it has
been possible to produce acantholytic skin
lesions like those of pemphigus (6). In order
to produce the acantholytic lesions, it was
necessary to increase the vascular permeability
so that the antibodies could permeate from
the plasma into the epidermis, and this was
achieved by the application to the shaved skin
of rabbits first of sodium lauryl sulfonate and
then of dry ice. Thus, it can be said that lesions
analogous to those of pemphigus vulgaris have
been reproduced in animals by the experimental
production of intercellular antibodies in such
animals.
ii. Bullous Pemphigoid
The antibodies present in the serum of pa-
tients with bullous pempbigoid are different
from the intercellular antibodies encountered
in pemphigus. The antibodies of bullous
pemphigoid, on indirect immunofiuorescent
;r
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Fio. 2. Bullous pemphigoid. Indirect immunofluorescent staining shows binding of anti-
bodies in the subepithelial basement zone.
testing, are bound to the subepithelial base-
ment zone (Fig. 2). As in the case of pemphi-
gus, the autoimmune etiology of bullous pem-
phigoid is suggested by the following facts:
1. The basement zone antibodies are auto-
antibodies (9).
2. The localization of the basement zone
antibodies of bullous pemphigoid corresponds
to the site of bulla formation.
3. The titer of the basement zone antibodies
in general is proportional to the severity of
the disease (12).
4. IgG and complement are concomitantly
bound in vivo in the basement zone (13).
II. ELECTRON MICROSCOPE FINDINGS
a. Pemphigus Vulgaris
I would like now to say a few words about
the recent electron microscopic studies on pem-
phigus vulgaris by Dr. Hashimoto and my-
self. Earlier, electron microscopic studies by
Wilgram, Caulfield and myself (14), presented
before this Society in 1960, had seemed to
indicate that damage to the tonofilaments was
the primary event followed by disintegration
of the desmosomes. However, when immunologic
studies had indicated that the antigen-antibody
reaction took place in the intercellular spaces
of squamous epithelium, Dr. Hashimoto and I
decided to pay closer attention to the inter-
cellular cement substance. With the improved
techniques that had become available since
1961, it could be demonstrated that dissolution
of the intercellular cement substance is the pri-
mary factor leading to acantholysis (7). Wher-
ever acantholysis is about to take place, the
cement substance is partially or entirely dis-
solved. One can observe this phenomenon best
in the oral mucosa where the epithelial cells
have only a few desmosomes and are held to-
gether largely by the intercellular cement
substance (Fig. 3). Concomitant with the dis-
solution of the intercellular cement substance
I 
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FIG. 3. Pemphigu, vulgaris. Oral mucosa. The intercellular cement substance still is intact
between two epithelial cells but not elsewhere. (X 6,630)
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Fic. 4. Pemphigus vulgaris. Oral mucosa. The intercellular cement substance has dissolved
and the intercellular space has widened whereas the desmosomes are still intact. (X 16,400)
the intercellular spaces widen at a time when
the desmosomes are still intact (Fig. 4). Only
as the intercellular space widens is there gradual
unlocking of the desmosomes (Fig. 5). At times,
partially dissolved cement is seen lying in
widened intercellular spaces (Fig. 6). iJiti-
mately, a serous exudate fills the intercellular
spaces and widens them further (Fig. 7).
In the epidermis where the cells have many
more and better developed desmosomes than in
the oral mucosa one observes the same phe-
nomenon: Dissolution of the intercellular ce-
ment substance with widening of the intercel-
lular spaces at a time when the desmosomes
and the tonofilaments attached to the desmo-
somes are still intact (Fig. 8). On widening of
the intercellular space one often sees the two
attachment plaques of a desmosome separate,
with the tonofilaments still being attached to
the attachment plaques, as shown in this cell
(Fig. 9). Retraction of the tonofilaments from
the desmosomes and disappearance of desmo-
somes thus clearly represent secondary phe-
nomena. Also, the trilaminar plasma membrane
of acantholytic cells is intact at the time acan-
tholysis sets in and often is still intact in cells
showing an advanced degree of degeneration
(8).
The basal ccli layer shows the so-called
tombstone arrangement with separation of the
basal cells not only from the overlying squa-
mous cells but also from one another (Fig.
10). However, the basal cells are firmly at-
tached to the basement membrane, now more
commonly referred to as basal lamina. The
basal lamina as well as the haif-desmosomes,
remain intact even in advanced lesions of pem-
phigus vulgaris, and also the bundles of tono-
ci, - - .--' "'
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Do. 5. Pemphi qua vulgaris. Oral mucosa. As the intercellular space widens the desmosomes
unlock. (X 15.200)
filaments remain attached to the half-desmo-
somes (Fig. 11).
Ruthenium red staining. In a recently com-
pleted hut as yet unpublished study (8), Dr.
Hashimoto and I used ruthenium red as an
electron histochemical stain for the intercellular
cement substance in specimens of pemphigus
vulgaris. With this stain, especially when uranyl
acetate and lead citrate were used subsequently,
there was an electron opaque appearance of
the intercellular cement substance as well as of
the intradesmosomal cement substance between
the two intermediate dense layers of each
desmosome, as had been previously described
by Wolff and Schrciner (15). Ruthenium red
staining demonstrated very well the dissolu-
tion of the electron opaque intercellular cement
substance (Fig. 12). Generally, dissolution of
the intradesmosomal cement and subsequent
separation of the two attachment plaques oc-
curred at a slightly later period after most of
the intercellular cement substance had already
dissolved and the intercellular space had wid-
ened.
Attachment of basal cells to basal lamina.
In the same study, the attachment of the basal
cells to the basal lamina was studied. It was
noted that neither in normal skin nor in any of
.
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FIG. 6. Pemphigu.s vulgaris. Oral mucosa. Partially dissolved cement substance is seen
lying in the widened intercellular space. (X 30,000)
Lhe pemphigus specimens did ruthenium red
penetrate into the electron lucent zone present
between the basal cell plasma membrane
with its haif-desmosomes and the basal lamina.
Thus, this electron lucent zone did not seem to
contain any intercellular cement substance.
Study of normal skin with a high resolution
electron microscope then revealed two struc-
tures in this electron lucent zone: first, an elec-
tron dense plaque beneath each half-demosome
referred to as sub-basal-cell dense plaques, and,
second, innumerable very fine filaments, re-
ferred to as anchoring filaments (Fig. 13).
Those filaments that were attached to half-
desmosomes extended vertically to the under-
lying sub-basal-cell dense plaque and from
there to the basal lamina, whereas filaments
not attached to the haif-desmosomes and sub-
basal-cell dense plaques showed an irregular
"criss-crossing" course from the basal cell
plasma membrane to the basal lamina. The
anchoring filaments and the sub-basal-cell
dense plaques in the electron ]ucent zone be-
tween basal cells and basal lamina showed no
damage even in far advanced lesions of pem-
phigus vulgaris. It can be postulated that
the preservation of these two structures in the
electron lucent zone in pemphigus vulgaris is
the reason why the basal cells remain attached
to the dermis in that disease.
b. Pemphiqus Foliaceus
Time does not permit a detailed discussion
of the electron microscopic findings in pem-
phigus foliaceus and bullous pemphigoid.
I should like to point out, however, that the
electron microscopic changes in pemphigus
foliaceus are similar to, but less severe than,
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Fic. 9. Pemphigus vulgori,s. Epidermis. Two intact attachment plaques and the intact
plasma membrane of an acantholytic cell are shown. (x 139,400)
those in pemphigus vulgaris. Thus, even though
the lower epidermis already shows some loss
of intercellular cement substance full acan-
tholysis occurs only in the upper layers of the
epidermis. As Wilgram and coworkers (16)
had already pointed out, in pemphigus foliaceus
the cells of the upper epidermis contain a
greatly increased number of membrane-coat-
ing granules or keratinosomes. These keratino-
somes appear abnormal because of a considerable
variation in their size (Fig. 14). On stain-
ing with ruthenium red, a portion of most kera-
tinosomes stained in the same way as the inter-
cellular cement, making it likely that when the
keratinosomes are discharged from the epi-
dermal cells into the intercellular space they
release a substance similar to the intercellular
cement.
c. Bullou.s Pemphiqoid
In regard to bullous pemphigoid, I should
just like to point cut that, in contrast to pem-
phigus vulgaris, there is considerable damage
to the basal lamina, which appears hazy and
ill defined; and the anchoring filaments, the
sub-basal-cell dense plaques and half-desmo-
somes have largely disappeared (Fig. 15). These
changes can be held responsible for the for-
ination of the subepidermal bullae in bullous
pemphigoid.
III. TREATMENT WITH METHOTREXATE
The strong evidence in favor of an auto-
immune etiology of pemphigus vulgaris, pem-
phigus foliaceus and bullous pemphigoid made
it seem logical to employ immunosuppressive
drugs in their treatment. Methotrexate has
proven to be of great value in the treatment
of pemphigus as well as bullous pemphigoid.
It had been used by us since November of 1967.
A paper describing the results obtained with
mcthotrexate in the first five patients with
pemphigus vulgaris will appear shortly in the
Archives of Dermatology (17).
Pemphigus vulgaris. The weekly adminis-
tration of methotrexate at present is our
treatment of choice in three groups of patients
with pemphigus vulgaris: first, in patients who
are in the early, localized stage of the disease;
second, in patients in whom the disease is in
remission after the administration of high doses
of glucocorticoids; and third, in patients in
whom the glucocarticoids are causing serious
side reactions. The nausea and also the poten-
tial toxicity inherent in high doses of metho-
trexate prevent its administration in doses high
n. — -
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Fio. 10. Pempihgus vulgari.s. Epidermis. A "tombstone row" of basal cells is attached to
the intact basal lamina. (X 3,443)
•
•
.4
384 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Fie. 11. Pemphigus vulgaris. Epidermis. Higher magnification of the attachment of dam-
aged basal cells to the intact basal lamina is shown. All the half-desmosomcs (arrows) are
intact whereas only one desmosome (D) connecting adjoining basal cells has remained in-
tact. ()< 14,760)
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Fro. 12. Pemphiqus vulgaris. Oral mucosa. Ruthenium red stain. Two adjoining epithelial
cells still are in part attached to one another by the electron opaque cement substance.
Where they are separated from one another, partially dissolved cement (C) is still attached
to the outer leaflet of the trilaminar plasma membrane as fuzzy, amorphous material.
(X 116,000)
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FIG. 13. Pemphigus vulgaris. Epidermis. High magnification of the attachment of two
basal cells to the basal lamina. All structures effecting the attachment, namely, the half-
desmosomes (H), the sub-basal-cell dense plaques (P), the anchoring filaments (F) and the
basal lamina (B) are intact. (X 136,000)
enough to briDg about an adequate control of
the disease in patients with very active pem-
phigus vulgaris. So far, the results have been
as follows:
Three patients who were in the early stage
of pemphigus vulgaris were treated only with
methotrexate. All three showed gradual im-
provement setting in after one or two months
of treatment. All three patients are still under
treatment and two of them still have a few
oral lesions (Fig. 15). Three patients with pem-
phigus vulgaris who were on maintenance
doses of prednisone were treated with metb-
otrexate. In two of them the disease was very
severe requiring maintenance doses of 45 and
30 mg of prednisone, respectively. The predni-
sone has been discontinued by now in two,
whereas one patient is still taking 5 mg of pred-
nisone daily. All three patients are still receiv-
ing methotrexate and one of them still has a
few lesions.
Two patients with pemphigus vulgaris who
had contracted vertebral fractures, one of them
while on high doses of prednisone and the other
while on maintenance doses of prednisone were
treated with methotrexate. The management
would have been difficult in both patients, had
methotrexate not been available, particularly
in the patient on high doses of prednisone be-
cause his disease was very active. Tbe latter
patient is still taking 10 mg of prednisone
daily which he requires for his asthma; the
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Fin. 14. Pemphigws foliaceus. Upper epidermis. Ruthenium red stain. An epidermal cell
shows four intact attachment plaque-tonofilament complexes and an intact plasma mem-
brane. Numerous keratinosomes (K) are present within a granular cell and some keratino-
somes have been extruded. (X 33,000)
other patient is off prednisone. Both patients
are still receiving methotrexate and still have
a few lesions.
Pemphigus foliaceus. One patient with lo-
calized pemphigus foliaceus, so-called pemphi-
gus erythematosus, who never had been treated
with prednisone cleared of his lesions in the
course of six months under treatment with
methotrexate.
Bullov.s pemphigod. Five patients with ac-
tive bullous pemphigoid were treated with
methotrexate alone. In four patients the re-
sponse was quite fast in that the lesions cleared
within about one month. In two of these pa
tients there was a recurrence of lesions which
again responded to methotrexate. In the fifth
patient the response has been more gradual
and, even after two months of treatment with
methotrexate, a few new lesions are continuing
to appear.
Method of treatment with met hotrexate.
In treating our patients with pemphigus and
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F'o. 15. Bullous pemphigoid. Border between epidermis and dermis. In contrast to pem-
phigus vulgaris (see Fig. 13) all structures involved in the attachment of the basal cell to
the basal lamina are damaged: the half-desmosomes and sub-basal cell dense plaques are
nearly absent, the anchoring filaments no longer recognizable and the basal lamina (B) ap-
pears hazy and ill-defined. (X 48,140)
bullous pemphigoid, methotrexate was given
once a week either intravenously or orally.
Intravenous administration is preferable to oral
administration in the beginning since, as a rule,
larger doses are tolerated without the develop-
ment of nausea. Prednisone in doses of 15 mg
a day or more exerts a protective effect against
the nausea and, for tbis reason, patients receiv-
ing maintenance doses of prednisone can toler-
ate higher doses of methotrexate than those not
receiving prednisone. In patients who develop
nausea from methotrexate, prednisone often is
effective in suppressing nausea when 20 or 30
mg of prednisone are given on the day before,
the day of and the day after the administra-
tion of methotrexate.
The initial dose of methotrexate when given
without prednisone generally has been 24 mg
and the dose has been raised by increments of
5 mg to the highest level tolerated, as high as
50 mg. In patients receiving maintenance
treatment with prednisone the initial dose of
methotrexate has been between 40 and 80 mg
and has been raised to 100 mg, if tolerated.
Generally, there has been a decrease in the
antibody titer under treatment with methotrex-
ate, but there has not always been a direct
relationship between the degree of improve-
ment and the decrease in the titer. Thus, deter-
minations of the antibody titer as a guide for
therapy or for the purpose of prognosis are
of very limited value.
Side reactions. A depression of the white
blood cell count occurred in two patients. In
one patient who had multiple vertebral frac-
tures and very active disease, the white blood
cell count decreased when methotrexate was
given intravenously every five days instead of
every seven days. Subsequently this patient
tolerated methotrexate well in doses up to 90
mg when it was given once a week. In the sec-
ond patient, a 72 year old woman, weekly
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doses of 30 mg of methotrexate caused a de-
pression of the white blood cell count, but later
on doses of 20 mg a week were tolerated.
CONCLTJSIONS
In conclusion, methotrexate appears to be
the treatment of choice in all patients with
bullous pemphigoid. In pemphigus vulgaris
it is the treatment of choice except for patients
with very active diseases in whom the treat-
ment should be started with large doses of pred-
nisone until the disease is under control. When
the patient is on maintenance doses of predni-
sone, methotrexate is started and the predni-
sone is gradually reduced and, if possible,
finally withdrawn. There is no question that for
prolonged treatment, as required in pemphigus
vulgarls, methotrexate is much safer than
prednisone; and the ultimate prognosis for
patients with pemphigus vulgaris has been
greatly improved by methotrexate.
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